Peroxidic antimalarials

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

This review provides an update of significant advances in the discovery of peroxidic antimalarial agents, covering the patent and corresponding scientific literature from late 1998 to early 2001. Many efforts have been directed towards producing new chemical entities with enhanced chemical stability and oral activity. In addition, new strategies are being explored, such as polychemotherapy and chimeric therapy, which may hold considerable promise in fighting drug resistance. Providing drug candidates with appropriate physico-chemical, pharmacokinetic and biopharmaceutical properties presents an enormous challenge for the current antimalarial research enterprise, which lacks significant industrial input.

Original languageEnglish (US)
Pages (from-to)1753-1760
Number of pages8
JournalExpert Opinion on Therapeutic Patents
Volume11
Issue number11
DOIs
StatePublished - Nov 20 2001

Fingerprint

Antimalarials
drug
Literature
technical literature
Combination Drug Therapy
Drug Resistance
patent
candidacy
Pharmacokinetics
lack
Research
Pharmaceutical Preparations
Therapeutics

Keywords

  • Antimalarials
  • Artemisinin derivatives
  • Artemisinin dimers
  • Endoperoxides
  • Tetroxocanes
  • Trioxanes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Peroxidic antimalarials. / Dong, Y.; Vennerstrom, J. L.

In: Expert Opinion on Therapeutic Patents, Vol. 11, No. 11, 20.11.2001, p. 1753-1760.

Research output: Contribution to journalReview article

@article{da2c4d90f1ef42fda6c17fcc2c8f015e,
title = "Peroxidic antimalarials",
abstract = "This review provides an update of significant advances in the discovery of peroxidic antimalarial agents, covering the patent and corresponding scientific literature from late 1998 to early 2001. Many efforts have been directed towards producing new chemical entities with enhanced chemical stability and oral activity. In addition, new strategies are being explored, such as polychemotherapy and chimeric therapy, which may hold considerable promise in fighting drug resistance. Providing drug candidates with appropriate physico-chemical, pharmacokinetic and biopharmaceutical properties presents an enormous challenge for the current antimalarial research enterprise, which lacks significant industrial input.",
keywords = "Antimalarials, Artemisinin derivatives, Artemisinin dimers, Endoperoxides, Tetroxocanes, Trioxanes",
author = "Y. Dong and Vennerstrom, {J. L.}",
year = "2001",
month = "11",
day = "20",
doi = "10.1517/13543776.11.11.1753",
language = "English (US)",
volume = "11",
pages = "1753--1760",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Peroxidic antimalarials

AU - Dong, Y.

AU - Vennerstrom, J. L.

PY - 2001/11/20

Y1 - 2001/11/20

N2 - This review provides an update of significant advances in the discovery of peroxidic antimalarial agents, covering the patent and corresponding scientific literature from late 1998 to early 2001. Many efforts have been directed towards producing new chemical entities with enhanced chemical stability and oral activity. In addition, new strategies are being explored, such as polychemotherapy and chimeric therapy, which may hold considerable promise in fighting drug resistance. Providing drug candidates with appropriate physico-chemical, pharmacokinetic and biopharmaceutical properties presents an enormous challenge for the current antimalarial research enterprise, which lacks significant industrial input.

AB - This review provides an update of significant advances in the discovery of peroxidic antimalarial agents, covering the patent and corresponding scientific literature from late 1998 to early 2001. Many efforts have been directed towards producing new chemical entities with enhanced chemical stability and oral activity. In addition, new strategies are being explored, such as polychemotherapy and chimeric therapy, which may hold considerable promise in fighting drug resistance. Providing drug candidates with appropriate physico-chemical, pharmacokinetic and biopharmaceutical properties presents an enormous challenge for the current antimalarial research enterprise, which lacks significant industrial input.

KW - Antimalarials

KW - Artemisinin derivatives

KW - Artemisinin dimers

KW - Endoperoxides

KW - Tetroxocanes

KW - Trioxanes

UR - http://www.scopus.com/inward/record.url?scp=0034763650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034763650&partnerID=8YFLogxK

U2 - 10.1517/13543776.11.11.1753

DO - 10.1517/13543776.11.11.1753

M3 - Review article

AN - SCOPUS:0034763650

VL - 11

SP - 1753

EP - 1760

JO - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

SN - 1354-3776

IS - 11

ER -